Alcohol: Do not consume alcohol while taking Hetnor-TZ Tablets or for at least 72 hours after completing treatment. Alcohol may cause a disulfiram-like reaction, resulting in flushing, rapid heartbeat, low blood pressure, nausea, vomiting, dizziness, lightheadedness, and severe headache.
Pregnancy: Hetnor-TZ Tablets are unsafe during pregnancy and should not be used unless specifically advised by your doctor. They may cause serious harm to the unborn baby, including birth defects or pregnancy loss.
Breastfeeding: Hetnor-TZ Tablets are not recommended during breastfeeding, as the medicine may pass into breast milk and could harm the nursing infant. Consult your doctor before use.
Driving: Hetnor-TZ Tablets may cause dizziness, drowsiness, impaired coordination, numbness, weakness, or reduced alertness. Do not drive or operate machinery if you experience any of these symptoms.
Kidney Disease: Use Hetnor-TZ Tablets with caution in patients with kidney disease. Dose adjustment may be required. This medicine is generally not recommended in patients with severe kidney disease unless advised by your doctor.
Liver Disease: Hetnor-TZ Tablets should be used with caution in patients with severe liver disease. Dose adjustment and close medical supervision may be required during treatment.